Elusys Therapeutics presents efficacy results and other key findings on ETI-204 Anthrax anti-toxin

Media Center PRESS RELEASE 2013 ELUSYS THERAPEUTICS PRESENTS EFFICACY RESULTS AND OTHER KEY FINDINGS ON ETI-204 ANTHRAX ANTI-TOXIN Data presented on results in healthy and infected animals, survival in combination with antibiotics, and development of adaptive immunity PINE BROOK, NJ AND VICTORIA, B.C., CANADA, SEPTEMBER 5, 2013 – Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company […]

Media advisory-Elusys Therapeutics to present results on ETI-204 Anthrax anti-toxin

Media Center PRESS RELEASE 2013 MEDIA ADVISORY ELUSYS THERAPEUTICS TO PRESENT RESULTS ON ETI-204 ANTHRAX ANTI-TOXIN PINE BROOK, NJ – Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, will present results of nonclinical studies evaluating the company’s anthrax anti-toxin therapy, ETI-204. ETI-204 is an investigational agent being developed for […]

Elusys releases new data on Anthrax anti-toxin administered via intramuscular injection from three recent animal studies

Media Center PRESS RELEASE 2013 ELUSYS RELEASES NEW DATA ON ANTHRAX ANTI-TOXIN ADMINISTERED VIA INTRAMUSCULAR INJECTION FROM THREE RECENT ANIMAL STUDIES PINE BROOK, NJ, JULY 31, 2013 – Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, today released data from three recently completed studies of ETI-204 (Anthim) administered by […]

Alliance for biosecurity elects Chief Executive Officers of Bavarian Nordic and Elusys Therapeutics as new co-chairs

Media Center PRESS RELEASE 2013 ALLIANCE FOR BIOSECURITY ELECTS CHIEF EXECUTIVE OFFICERS OF BAVARIAN NORDIC AND ELUSYS THERAPEUTICS AS NEW CO-CHAIRS Leadership Team Will Advance Industry Efforts Supporting the Development of Medical Countermeasures Against National Security Threats WASHINGTON, DC – JULY 1, 2013 – The Alliance for Biosecurity announced it recently elected Anders Hedegaard, President […]